Can elevated urine D-arabinitol and citramalic acid reflect altered microbial metabolism even when stool mycology culture is negative?

Clinical and diagnostic evidence

• Sensitivity limitations of stool cultures: Standard stool mycology cultures are frequently limited by low sensitivity, capturing only transient luminal contents rather than localized mucosal colonization or systemic yeast activity.
• Detection of occult colonization: Urinary D-arabinitol and its ratio to L-arabinitol provide a highly sensitive, systemic reflection of active Candida metabolism. This metabolic marker can detect active fungal burdens even when stool cultures fail to grow viable colonies.

Mechanistic explanations

• D-arabinitol synthesis: Urinary D-arabinitol is synthesized via the pentose phosphate pathway of pathogenic Candida species. Because human tissue does not produce this stereoisomer in significant quantities, its presence in the urine serves as a direct metabolic byproduct of fungal carbohydrate metabolism.
• Citramalic acid production: Citramalic acid is synthesized by specific yeast species, including Saccharomyces, and certain anaerobic bacteria like Clostridia through the condensation of pyruvate and acetyl-CoA. Human cells lack the metabolic machinery to produce significant levels of citramalic acid, making its urinary elevation a distinct marker of altered microbial metabolism.

Bottom line

• Elevated urinary D-arabinitol and citramalic acid are highly sensitive, reliable metabolic indicators of yeast and anaerobic bacterial overgrowth that can detect altered microbial metabolism even when standard stool mycology cultures return negative results.